{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T10:10:10Z","timestamp":1699351810822},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1007\/s00115-004-1783-7","type":"journal-article","created":{"date-parts":[[2004,12,3]],"date-time":"2004-12-03T11:31:46Z","timestamp":1102073506000},"page":"131-142","source":"Crossref","is-referenced-by-count":2,"title":["Multiple Sklerose und Ern\u00e4hrung","Diet and multiple sclerosis"],"prefix":"10.1007","volume":"76","author":[{"given":"S.","family":"Schwarz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Leweling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S0140-6736(74)92163-1","volume":"2","author":"Agranoff","year":"1974","unstructured":"Agranoff BW, Goldberg D (1974) Diet and the geographical distribution of multiple sclerosis. Lancet 2:1061\u20131066","journal-title":"Lancet"},{"key":"1783_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1056\/NEJMoa012918","volume":"346","author":"Albert","year":"2002","unstructured":"Albert CM, Campos H, Stampfer MJ et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346:1113\u20131118","journal-title":"N Engl J Med"},{"key":"1783_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(71)90478-1","volume":"35","author":"Alling","year":"1971","unstructured":"Alling C, Vanier MT, Svennerholm L (1971) Lipid alterations in apparently normal white matter in multiple sclerosis. Brain Res 35:325\u2013336","journal-title":"Brain Res"},{"key":"1783_CR4","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1001\/archneur.1974.00490400081010","volume":"31","author":"Alter","year":"1974","unstructured":"Alter M, Yamoor M, Harshe M (1974) Multiple sclerosis and nutrition. Arch Neurol 31:267\u2013272","journal-title":"Arch Neurol"},{"key":"1783_CR5","first-page":"253","volume":"98","author":"Alter","year":"1973","unstructured":"Alter M, Yamour M (1973) Multiple sclerosis prevalence and nutritional factors. Trans Am Neurol Assoc 98:253\u2013254","journal-title":"Trans Am Neurol Assoc"},{"key":"1783_CR6","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archneur.1965.00470020073010","volume":"13","author":"Antonovsky","year":"1965","unstructured":"Antonovsky A, Leibowitz U, Smith HA (1965) Epidemiologic study of multiple sclerosis in Israel. I. An overall review of methods and findings. Arch Neurol 13:183\u2013193","journal-title":"Arch Neurol"},{"key":"1783_CR7","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1471-4159.1969.tb10387.x","volume":"16","author":"Arnetoli","year":"1969","unstructured":"Arnetoli G, Pazzagli A, Amaducci L (1969) Fatty acid and aldehyde changes in choline- and ethanolamine-containing phospholipids in the white matter of multiple sclerosis brains. J Neurochem 16:461\u2013463","journal-title":"J Neurochem"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0140-6736(63)91152-8","volume":"1","author":"Baker","year":"1963","unstructured":"Baker RW, Thompson RH, Zilkha KJ (1963) Fatty-acid composition of brain lecithins in multiple sclerosis. Lancet 1:26\u201327","journal-title":"Lancet"},{"key":"1783_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jnnp.52.1.18","volume":"52","author":"Bates","year":"1989","unstructured":"Bates D, Cartlidge NE, French JM et al. (1989) A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 52:18\u201322","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bmj.2.6149.1390","volume":"2","author":"Bates","year":"1978","unstructured":"Bates D, Fawcett PR, Shaw DA et al. (1978) Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis. Br Med J 2:1390\u20131391","journal-title":"Br Med J"},{"key":"1783_CR11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0404.1989.tb03841.x","volume":"80","author":"Berr","year":"1989","unstructured":"Berr C, Puel J, Clanet M et al. (1989) Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrenees, France. Acta Neurol Scand 80:46\u201350","journal-title":"Acta Neurol Scand"},{"key":"1783_CR12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11940-003-0022-z","volume":"5","author":"Bowling","year":"2003","unstructured":"Bowling AC, Stewart TM (2003) Current complementary and alternative therapies for multiple sclerosis. Curr Treat Options Neurol 5:55\u201368","journal-title":"Curr Treat Options Neurol"},{"key":"1783_CR13","first-page":"427","volume":"83","author":"Butcher","year":"1976","unstructured":"Butcher J (1976) The distribution of multiple sclerosis in relation to the dairy industry and milk consumption. N Z Med J 83:427\u2013430","journal-title":"N Z Med J"},{"key":"1783_CR14","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1007\/BF02562264","volume":"34","author":"Calder","year":"1999","unstructured":"Calder PC (1999) Dietary fatty acids and the immune system. Lipids 34 [Suppl]:137\u2013140","journal-title":"Lipids"},{"key":"1783_CR15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s11745-001-0812-7","volume":"36","author":"Calder","year":"2001","unstructured":"Calder PC (2001) Polyunsaturated fatty acids, inflammation, and immunity. Lipids 36:1007\u20131024","journal-title":"Lipids"},{"key":"1783_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1006\/abbi.2000.1765","volume":"377","author":"Cantorna","year":"2000","unstructured":"Cantorna M, Humpal-Winter J, DeLuca H (2000) In vivo upregulation of interleukin-4 is one mechanism underlying the immunoregulatory effects of 1,25-dihydroxyvitamin D3. Arch Biochem Biophys 377:135\u2013138","journal-title":"Arch Biochem Biophys"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"7861","DOI":"10.1073\/pnas.93.15.7861","volume":"93","author":"Cantorna","year":"1996","unstructured":"Cantorna MT, Hayes CE, DeLuca HF (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci USA 93:7861\u20137864","journal-title":"Proc Natl Acad Sci USA"},{"key":"1783_CR18","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000113777","volume":"2","author":"Cendrowski","year":"1969","unstructured":"Cendrowski W, Wender M, Dominik W et al. (1969) Epidemiological study of multiple sclerosis in western Poland. Eur Neurol 2:90\u2013108","journal-title":"Eur Neurol"},{"key":"1783_CR19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02990136","volume":"15","author":"Clausen","year":"1988","unstructured":"Clausen J, Jensen GE, Nielsen SA (1988) Selenium in chronic neurologic diseases. Multiple sclerosis and Batten\u2019s disease. Biol Trace Elem Res 15:179\u2013203","journal-title":"Biol Trace Elem Res"},{"key":"1783_CR20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1600-0404.1967.tb05740.x","volume":"43","author":"Clausen","year":"1967","unstructured":"Clausen J, Moller J (1967) Allergic encephalomyelitis induced by brain antigen after deficiency in polyunsaturated fatty acids during myelination. Is multiple sclerosis a nutritive disorder? Acta Neurol Scand 43:375\u2013388","journal-title":"Acta Neurol Scand"},{"key":"1783_CR21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0404.1967.tb02065.x","volume":"43","author":"Clausen","year":"1967","unstructured":"Clausen J, Moller J (1967) Experimental allergic encephalomyelitis provoked in rats after developmental lack of polyunsaturated tally acids. Acta Neurol Scand 43 [Suppl 31]:74","journal-title":"Acta Neurol Scand"},{"key":"1783_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000073969","volume":"23","author":"Coo","year":"2004","unstructured":"Coo H, Aronson KJ (2004) A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 23:1\u201312","journal-title":"Neuroepidemiology"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/S0140-6736(78)92445-5","volume":"i","author":"Cook","year":"1978","unstructured":"Cook AW, Gupta JK, Pertschuk LP et al. (1978) Multiple sclerosis and malabsorption. Lancet i:1366","journal-title":"Lancet"},{"key":"1783_CR24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.51.4.1161","volume":"51","author":"Cosman","year":"1998","unstructured":"Cosman F, Nieves J, Komar L et al. (1998) Fracture history and bone loss in patients with MS. Neurology 51:1161\u20131165","journal-title":"Neurology"},{"key":"1783_CR25","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jcp.18.5.641","volume":"18","author":"Cumings","year":"1965","unstructured":"Cumings JN, Shortman RC, Skrbic T (1965) Lipid studies in the blood and brain in multiple sclerosis and motor neurone disease. J Clin Pathol 18:641\u2013644","journal-title":"J Clin Pathol"},{"key":"1783_CR26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/50.4.801","volume":"50","author":"Cunnane","year":"1989","unstructured":"Cunnane SC, Ho SY, Dore-Duffy P et al. (1989) Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis. Am J Clin Nutr 50:801\u2013806","journal-title":"Am J Clin Nutr"},{"key":"1783_CR27","unstructured":"Deutsche Gesellschaft f\u00fcr Ern\u00e4hrung (DGE) (1999) Tips der Deutschen Gesellschaft f\u00fcr Ern\u00e4hrung e.V. zur Ern\u00e4hrung bei Multipler Sklerose. http:\/\/www.dge.de\/Pages\/navigation\/presse\/akt1099.htm, accessed 03.05.2004."},{"key":"1783_CR28","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.34.11.1441","volume":"34","author":"Dworkin","year":"1984","unstructured":"Dworkin RH, Bates D, Millar JH et al. (1984) Linoleic acid and multiple sclerosis: a reanalysis of three double-blind trials. Neurology 34:1441\u20131445","journal-title":"Neurology"},{"key":"1783_CR29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/1531-8249(200008)48:2<271::AID-ANA28>3.0.CO;2-O","volume":"48","author":"Embry","year":"2000","unstructured":"Embry AF, Snowdon LR, Vieth R (2000) Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 48:271\u2013272","journal-title":"Ann Neurol"},{"key":"1783_CR30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/oxfordjournals.aje.a117704","volume":"142","author":"Esparza","year":"1995","unstructured":"Esparza ML, Sasaki S, Kesteloot H (1995) Nutrition, latitude, and multiple sclerosis mortality: an ecologic study. Am J Epidemiol 142:733\u2013737","journal-title":"Am J Epidemiol"},{"key":"1783_CR31","first-page":"1700","volume":"31","author":"Evers","year":"1969","unstructured":"Evers J (1969) Die di\u00e4tetische Therapie der Multiplen Sklerose. Kasuistik und Epikrise meiner ersten durch Di\u00e4t geheilten Multiple-Sklerose-Patienten nach einer Verlaufsbeobachtungszeit von 20\u00a0Jahren und Bericht \u00fcber meine anderen 9000 di\u00e4tetisch behandelten Multiple-Sklerose-Patienten. Med Welt 31:1700\u20131707","journal-title":"Med Welt"},{"key":"1783_CR32","unstructured":"Evers J (2002) Die Evers-Di\u00e4t, 13. Aufl. Haug, Stuttgart"},{"key":"1783_CR33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/00004650-199401000-00008","volume":"8","author":"Fawcett","year":"1994","unstructured":"Fawcett J, Sidney JS, Hanson MJ et al. (1994) Use of alternative health therapies by people with multiple sclerosis: an exploratory study. Holist Nurs Pract 8:36\u201342","journal-title":"Holist Nurs Pract"},{"key":"1783_CR34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0404.1987.tb03574.x","volume":"76","author":"Fisher","year":"1987","unstructured":"Fisher M, Johnson MH, Natale AM et al. (1987) Linoleic acid levels in white blood cells, platelets, and serum of multiple sclerosis patients. Acta Neurol Scand 76:241\u2013245","journal-title":"Acta Neurol Scand"},{"key":"1783_CR35","first-page":"A338","volume":"54","author":"Fleming","year":"2000","unstructured":"Fleming JO, Hummel AL, Beinlich BR et al. (2000) Vitamin D treatment of relapsing-remitting multiple sclerosis (RRMS): a MRI-based pilot study. Neurology 54:A338","journal-title":"Neurology"},{"key":"1783_CR36","first-page":"142","volume":"3","author":"Fratzer","year":"1992","unstructured":"Fratzer U (1992) Multiple Sklerose: Eine neue Therapie vor der Blut-Hirn-Schranke. VitaMinSpur 3:142\u2013147","journal-title":"VitaMinSpur"},{"key":"1783_CR37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1136\/oem.57.6.418","volume":"57","author":"Freedman","year":"2000","unstructured":"Freedman DM, Dosemeci M, Alavanja MC (2000) Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med 57:418\u2013421","journal-title":"Occup Environ Med"},{"key":"1783_CR38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00838168","volume":"240","author":"Frequin","year":"1993","unstructured":"Frequin ST, Wevers RA, Braam M et al. (1993) Decreased vitamin B12 and folate levels in cerebrospinal fluid and serum of multiple sclerosis patients after high-dose intravenous methylprednisolone. J Neurol 240:305\u2013308","journal-title":"J Neurol"},{"key":"1783_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0165-5728(94)00140-J","volume":"56","author":"Gallai","year":"1995","unstructured":"Gallai V, Sarchielli P, Trequattrini A et al. (1995) Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids. J Neuroimmunol 56:143\u2013153","journal-title":"J Neuroimmunol"},{"key":"1783_CR40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/ije\/27.5.845","volume":"27","author":"Ghadirian","year":"1998","unstructured":"Ghadirian P, Jain M, Ducic S et al. (1998) Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol 27:845\u2013852","journal-title":"Int J Epidemiol"},{"issue":"Suppl 2","key":"1783_CR41","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1007\/s100720100048","volume":"22","author":"A Ghezzi","year":"2001","unstructured":"Ghezzi A, Zaffaroni M (2001) Neurological manifestations of gastrointestinal disorders, with particular reference to the differential diagnosis of multiple sclerosis. Neurol Sci 22(Suppl\u00a02):S117\u2013122","journal-title":"Neurol Sci"},{"key":"1783_CR42","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/BF02537067","volume":"27","author":"Gibson","year":"1992","unstructured":"Gibson RA, Lines DR, Neumann MA (1992) Gamma linolenic acid (GLA) content of encapsulated evening primrose oil products. Lipids 27:82\u201384","journal-title":"Lipids"},{"key":"1783_CR43","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/S0028-3908(01)00019-3","volume":"40","author":"Gilgun-Sherki","year":"2001","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2001) Oxidative stress-induced neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Neuropharmacology 40:959\u2013975","journal-title":"Neuropharmacology"},{"key":"1783_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00415-004-0348-9","volume":"251","author":"Gilgun-Sherki","year":"2004","unstructured":"Gilgun-Sherki Y, Melamed E, Offen D (2004) The role of oxidative stress in the pathogenesis of multiple sclerosis: the need for effective antioxidant therapy. J Neurol 251:261\u2013268","journal-title":"J Neurol"},{"key":"1783_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0306-9877(86)90010-1","volume":"21","author":"Goldberg","year":"1986","unstructured":"Goldberg P, Fleming MC, Picard EH (1986) Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 21:193\u2013200","journal-title":"Med Hypotheses"},{"key":"1783_CR46","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archneur.1994.00540230048011","volume":"51","author":"Goodkin","year":"1994","unstructured":"Goodkin DE, Jacobsen DW, Galvez N et al. (1994) Serum cobalamin deficiency is uncommon in multiple sclerosis. Arch Neurol 51:1110\u20131114","journal-title":"Arch Neurol"},{"key":"1783_CR47","first-page":"562","volume":"57","author":"Grann","year":"1961","unstructured":"Grann V, Glass GB (1961) Blood serum levels and intestinal absorption of vitamin B12 in multiple sclerosis. J Lab Clin Med 57:562\u2013567","journal-title":"J Lab Clin Med"},{"key":"1783_CR48","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1136\/jnnp.33.4.506","volume":"33","author":"Gul","year":"1970","unstructured":"Gul S, Smith AD, Thompson RH et al. (1970) Fatty acid composition of phospholipids from platelets and erythrocytes in multiple sclerosis. J Neurol Neurosurg Psychiatry 33:506\u2013510","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR49","first-page":"560","volume":"68","author":"Gupta","year":"1977","unstructured":"Gupta JK, Ingegno AP, Cook AW et al. (1977) Multiple sclerosis and malabsorption. Am J Gastroenterol 68:560\u2013565","journal-title":"Am J Gastroenterol"},{"key":"1783_CR50","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0404.1996.tb00050.x","volume":"94","author":"Gusev","year":"1996","unstructured":"Gusev E, Boiko A, Lauer K et al. (1996) Environmental risk factors in MS: a case-control study in Moscow. Acta Neurol Scand 94:386\u2013394","journal-title":"Acta Neurol Scand"},{"key":"1783_CR51","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1079\/PNS19980081","volume":"57","author":"Harbige","year":"1998","unstructured":"Harbige LS (1998) Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc 57:555\u2013562","journal-title":"Proc Nutr Soc"},{"key":"1783_CR52","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11745-003-1067-z","volume":"38","author":"Harbige","year":"2003","unstructured":"Harbige LS (2003) Fatty acids, the immune response, and autoimmunity: a question of n-6 essentiality and the balance between n-6 and n-3. Lipids 38:323\u2013341","journal-title":"Lipids"},{"key":"1783_CR53","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1046\/j.1365-2249.2000.01399.x","volume":"122","author":"Harbige","year":"2000","unstructured":"Harbige LS, Layward L, Morris-Downes MM et al. (2000) The protective effects of omega-6 fatty acids in experimental autoimmune encephalomyelitis (EAE) in relation to transforming growth factor-beta 1 (TGF-beta1) up-regulation and increased prostaglandin E2 (PGE2) production. Clin Exp Immunol 122:445\u2013452","journal-title":"Clin Exp Immunol"},{"key":"1783_CR54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1079\/BJN19950173","volume":"74","author":"Harbige","year":"1995","unstructured":"Harbige LS, Yeatman N, Amor S et al. (1995) Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of gamma-linolenic acid. Br J Nutr 74:701\u2013715","journal-title":"Br J Nutr"},{"key":"1783_CR55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1017\/S0029665100000768","volume":"59","author":"Hayes","year":"2000","unstructured":"Hayes CE (2000) Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 59:531\u2013535","journal-title":"Proc Nutr Soc"},{"key":"1783_CR56","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3181\/00379727-216-44153A","volume":"216","author":"Hayes","year":"1997","unstructured":"Hayes CE, Cantorna MT, DeLuca HF (1997) Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 216:21\u201327","journal-title":"Proc Soc Exp Biol Med"},{"key":"1783_CR57","first-page":"277","volume":"49","author":"Hayes","year":"2003","unstructured":"Hayes CE, Nashold FE, Spach KM et al. (2003) The immunological functions of the vitamin D endocrine system. Cell Mol Biol 49:277\u2013300","journal-title":"Cell Mol Biol"},{"key":"1783_CR58","first-page":"Theorie","volume":"Hoffnung","author":"Hebener","year":"1998","unstructured":"Hebener O (1998) Fundamente der Hoffnung: Theorie und Therapie der Multiplen Sklerose. Verlag Medizin und Gesundheit, Heidelberg","journal-title":"Fundamente der"},{"key":"1783_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1055\/s-2002-35077","volume":"51","author":"Hebener","year":"2002","unstructured":"Hebener O, Ackermann H, Kappel U et al. (2002) Empirische Untersuchungen zur Progressionsminderung der Multiplen Sklerose durch eine erg\u00e4nzende bilanzierte Di\u00e4t. Erfahrungsheilkunde 51:675\u2013681","journal-title":"Erfahrungsheilkunde"},{"key":"1783_CR60","first-page":"5","volume":"2","author":"Herndon","year":"2000","unstructured":"Herndon R, Mohandas N (2000) Osteoporosis in multiple sclerosis: a frequent, serious, and under-recognized problem. Int J MS Care 2:5","journal-title":"Int J MS Care"},{"key":"1783_CR61","first-page":"355","volume":"38","author":"Hewson","year":"1984","unstructured":"Hewson DC, Phillips MA, Simpson KE et al. (1984) Food intake in multiple sclerosis. Hum Nutr Appl Nutr 38:355\u2013367","journal-title":"Hum Nutr Appl Nutr"},{"key":"1783_CR62","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1073\/pnas.86.12.4720","volume":"86","author":"Holman","year":"1989","unstructured":"Holman RT, Johnson SB, Kokmen E (1989) Deficiencies of polyunsaturated fatty acids and replacement by nonessential fatty acids in plasma lipids in multiple sclerosis. Proc Natl Acad Sci USA 86:4720\u20134724","journal-title":"Proc Natl Acad Sci USA"},{"key":"1783_CR63","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/0306-9877(79)90018-5","volume":"5","author":"Horrobin","year":"1979","unstructured":"Horrobin DF (1979) Multiple sclerosis: the rational basis for treatment with colchicine and evening primrose oil. Med Hypotheses 5:365\u2013378","journal-title":"Med Hypotheses"},{"key":"1783_CR64","first-page":"Pharmacist","volume":"database","author":"Jellin","year":"2002","unstructured":"Jellin J, Gregory P, Batz F (2002) Natural medicines comprehensive database: Pharmacist\u2019s letter\/Prescriber\u2019s letter natural medicine comprehensive database. Therapeutic Research Faculty, Stockton","journal-title":"Natural medicines comprehensive"},{"key":"1783_CR65","doi-asserted-by":"crossref","first-page":"S450","DOI":"10.1111\/j.1600-0773.1986.tb02800.x","volume":"Toxicol","author":"Jensen","year":"1986","unstructured":"Jensen C, Clausen J (1986) Glutathione peroxidase activity, associated enzymes and substrates in blood cells from patients with multiple sclerosis\u2014effects of antioxidant supplementation. Acta Pharmacol Toxicol (Copenh) 59:S450-S453","journal-title":"Acta Pharmacol"},{"key":"1783_CR66","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0022-510X(80)90150-1","volume":"48","author":"Jensen","year":"1980","unstructured":"Jensen GE, Gissel-Nielsen G, Clausen J (1980) Leucocyte glutathione peroxidase activity and selenium level in multiple sclerosis. J Neurol Sci 48:61\u201367","journal-title":"J Neurol Sci"},{"key":"1783_CR67","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0304-3940(98)00370-X","volume":"249","author":"Jimenez-Jimenez","year":"1998","unstructured":"Jimenez-Jimenez FJ, de Bustos F, Molina JA et al. (1998) Cerebrospinal fluid levels of alpha-tocopherol in patients with multiple sclerosis. Neurosci Lett 249:65\u201367","journal-title":"Neurosci Lett"},{"key":"1783_CR68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2169\/internalmedicine.33.82","volume":"33","author":"Kira","year":"1994","unstructured":"Kira J, Tobimatsu S, Goto I (1994) Vitamin B12 metabolism and massive-dose methyl vitamin B12 therapy in Japanese patients with multiple sclerosis. Intern Med 33:82\u201386","journal-title":"Intern Med"},{"key":"1783_CR69","first-page":"71","volume":"31","author":"Knox","year":"1977","unstructured":"Knox EG (1977) Foods and diseases. Br J Prev Soc Med 31:71\u201380","journal-title":"Br J Prev Soc Med"},{"key":"1783_CR70","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000038493.65177.94","volume":"106","author":"Kris-Etherton","year":"2002","unstructured":"Kris-Etherton PM, Harris WS, Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747\u20132757","journal-title":"Circulation"},{"key":"1783_CR71","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000110199","volume":"8","author":"Lauer","year":"1989","unstructured":"Lauer K (1989) Multiple sclerosis in relation to meat preservation in France and Switzerland. Neuroepidemiology 8:308\u2013315","journal-title":"Neuroepidemiology"},{"key":"1783_CR72","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0895-4356(94)90032-9","volume":"47","author":"Lauer","year":"1994","unstructured":"Lauer K (1994) The risk of multiple sclerosis in the U.S.A. in relation to sociogeographic features: a factor-analytic study. J Clin Epidemiol 47:43\u201348","journal-title":"J Clin Epidemiol"},{"key":"1783_CR73","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1995.tb05861.x","volume":"161","author":"Lauer","year":"1995","unstructured":"Lauer K (1995) Environmental associations with the risk of multiple sclerosis: the contribution of ecological studies. Acta Neurol Scand Suppl 161:77\u201388","journal-title":"Acta Neurol Scand Suppl"},{"key":"1783_CR74","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1212\/WNL.49.2_Suppl_2.S55","volume":"49","author":"Lauer","year":"1997","unstructured":"Lauer K (1997) Diet and multiple sclerosis. Neurology 49:S55\u2013S61","journal-title":"Neurology"},{"key":"1783_CR75","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0021-9681(86)90079-2","volume":"39","author":"Lauer","year":"1986","unstructured":"Lauer K, Firnhaber W (1986) An evaluation of laboratory investigations in patients with multiple sclerosis. J Chronic Dis 39:767\u2013774","journal-title":"J Chronic Dis"},{"key":"1783_CR76","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","volume":"105","author":"Marchioli","year":"2002","unstructured":"Marchioli R, Barzi F, Bomba E et al. (2002) Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI)-Prevenzione. Circulation 105:1897\u20131903","journal-title":"Circulation"},{"key":"1783_CR77","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1159\/000115600","volume":"22","author":"Mazzella","year":"1983","unstructured":"Mazzella GL, Sinforiani E, Savoldi F et al. (1983) Blood cells glutathione peroxidase activity and selenium in multiple sclerosis. Eur Neurol 22:442\u2013446","journal-title":"Eur Neurol"},{"key":"1783_CR78","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0022-510X(78)90010-2","volume":"35","author":"Meade","year":"1978","unstructured":"Meade CJ, Mertin J, Sheena J et al. (1978) Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci 35:291\u2013308","journal-title":"J Neurol Sci"},{"key":"1783_CR79","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/bmj.1.5856.765","volume":"1","author":"Millar","year":"1973","unstructured":"Millar JH, Zilkha KJ, Langman MJ et al. (1973) Double-blind trial of linoleate supplementation of the diet in multiple sclerosis. Br Med J 1:765\u2013768","journal-title":"Br Med J"},{"key":"1783_CR80","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1212\/01.WNL.0000101723.79681.38","volume":"62","author":"Munger","year":"2004","unstructured":"Munger KL, Zhang SM, O\u2019Reilly E et al. (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62:60\u201365","journal-title":"Neurology"},{"key":"1783_CR81","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0306-9877(90)90083-Q","volume":"33","author":"Murrell","year":"1990","unstructured":"Murrell TG, Matthews BJ (1990) Multiple sclerosis\u2014one manifestation of neurobrucellosis? Med Hypotheses 33:43\u201348","journal-title":"Med Hypotheses"},{"key":"1783_CR82","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0165-5728(99)00247-7","volume":"103","author":"Nashold","year":"2000","unstructured":"Nashold FE, Miller DJ, Hayes CE (2000) 1,25 dihydroxyvitamin D3 treatment decreases macrophage accumulation in the CNS of mice with experimental autoimmune encephalomyelitis. J Neuroimmunol 103:171\u2013179","journal-title":"J Neuroimmunol"},{"key":"1783_CR83","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-0404.1988.tb03637.x","volume":"78","author":"Navarro","year":"1988","unstructured":"Navarro X, Segura R (1988) Plasma lipids and their fatty acid composition in multiple sclerosis. Acta Neurol Scand 78:152\u2013157","journal-title":"Acta Neurol Scand"},{"key":"1783_CR84","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0404.1983.tb04558.x","volume":"67","author":"Neu","year":"1983","unstructured":"Neu IS (1983) Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients. Acta Neurol Scand 67:151\u2013163","journal-title":"Acta Neurol Scand"},{"key":"1783_CR85","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1212\/WNL.44.9.1687","volume":"44","author":"Nieves","year":"1994","unstructured":"Nieves J, Cosman F, Herbert J et al. (1994) High prevalence of vitamin D deficiency and reduced bone mass in multiple sclerosis. Neurology 44:1687\u20131692","journal-title":"Neurology"},{"key":"1783_CR86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0404.1990.tb01586.x","volume":"82","author":"Nightingale","year":"1990","unstructured":"Nightingale S, Woo E, Smith AD et al. (1990) Red blood cell and adipose tissue fatty acids in mild inactive multiple sclerosis. Acta Neurol Scand 82:43\u201350","journal-title":"Acta Neurol Scand"},{"key":"1783_CR87","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/jnnp.53.11.951","volume":"53","author":"Nijst","year":"1990","unstructured":"Nijst TQ, Wevers RA, Schoonderwaldt HC et al. (1990) Vitamin B12 and folate concentrations in serum and cerebrospinal fluid of neurological patients with special reference to multiple sclerosis and dementia. J Neurol Neurosurg Psychiatry 53:951\u2013954","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR88","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1034\/j.1600-0404.2000.102003143.x","volume":"102","author":"Nordvik","year":"2000","unstructured":"Nordvik I, Myhr KM, Nyland H et al. (2000) Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 102:143\u2013149","journal-title":"Acta Neurol Scand"},{"key":"1783_CR89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3181\/00379727-103-25451","volume":"103","author":"O","year":"1960","unstructured":"O\u2019Connor JS, Davis RL, Langworthy OR et al. (1960) B12 metabolism and multiple sclerosis. Proc Soc Exp Biol Med 103:180\u2013183","journal-title":"Proc Soc Exp Biol Med"},{"key":"1783_CR90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1600-0404.1978.tb02859.x","volume":"58","author":"Paty","year":"1978","unstructured":"Paty DW, Cousin HK, Read S et al. (1978) Linoleic acid in multiple sclerosis: failure to show any therapeutic benefit. Acta Neurol Scand 58:53\u201358","journal-title":"Acta Neurol Scand"},{"key":"1783_CR91","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1046\/j.1365-277X.2001.00308.x","volume":"14","author":"Payne","year":"2001","unstructured":"Payne A (2001) Nutrition and diet in the clinical management of multiple sclerosis. J Hum Nutr Diet 14:349\u2013357","journal-title":"J Hum Nutr Diet"},{"key":"1783_CR92","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1136\/bmj.308.6941.1411","volume":"308","author":"Pisacane","year":"1994","unstructured":"Pisacane A, Impagliazzo N, Russo M et al. (1994) Breast feeding and multiple sclerosis. BMJ 308:1411\u20131412","journal-title":"BMJ"},{"key":"1783_CR93","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/jech.34.4.240","volume":"34","author":"Poskanzer","year":"1980","unstructured":"Poskanzer DC, Sheridan JL, Prenney LB et al. (1980) Multiple sclerosis in the Orkney and Shetland islands. II: The search for an exogenous aetiology. J Epidemiol Community Health 34:240\u2013252","journal-title":"J Epidemiol Community Health"},{"key":"1783_CR94","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0165-5728(92)90137-A","volume":"40","author":"Reynolds","year":"1992","unstructured":"Reynolds EH (1992) Multiple sclerosis and vitamin B12 metabolism. J Neuroimmunol 40:225\u2013230","journal-title":"J Neuroimmunol"},{"key":"1783_CR95","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/S0140-6736(87)91411-5","volume":"2","author":"Reynolds","year":"1987","unstructured":"Reynolds EH, Linnell JC (1987) Vitamin B12 deficiency, demyelination, and multiple sclerosis. Lancet 2:920","journal-title":"Lancet"},{"key":"1783_CR96","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneur.1991.00530200044017","volume":"48","author":"Reynolds","year":"1991","unstructured":"Reynolds EH, Linnell JC, Faludy JE (1991) Multiple sclerosis associated with vitamin B12 deficiency. Arch Neurol 48:808\u2013811","journal-title":"Arch Neurol"},{"key":"1783_CR97","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3109\/00207459309000596","volume":"71","author":"Sandyk","year":"1993","unstructured":"Sandyk R, Awerbuch GI (1993) Vitamin B12 and its relationship to age of onset of multiple sclerosis. Int J Neurosci 71:93\u201399","journal-title":"Int J Neurosci"},{"key":"1783_CR98","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.52.3.626","volume":"52","author":"Schwartz","year":"1999","unstructured":"Schwartz CE, Laitin E, Brotman S et al. (1999) Utilization of unconventional treatments by persons with MS: is it alternative or complementary? Neurology 52:626\u2013629","journal-title":"Neurology"},{"key":"1783_CR99","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000110322","volume":"12","author":"Sepcic","year":"1993","unstructured":"Sepcic J, Mesaros E, Materljan E et al. (1993) Nutritional factors and multiple sclerosis in Gorski Kotar, Croatia. Neuroepidemiology 12:234\u2013240","journal-title":"Neuroepidemiology"},{"key":"1783_CR100","unstructured":"Seviton Online Shop (2004) http:\/\/www.seviton.de\/shop.html, accessed 03.05.2004"},{"key":"1783_CR101","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/15246090050020709","volume":"9","author":"Shabas","year":"2000","unstructured":"Shabas D, Weinreb H (2000) Preventive healthcare in women with multiple sclerosis. J Womens Health Gend Based Med 9:389\u2013395","journal-title":"J Womens Health Gend Based Med"},{"key":"1783_CR102","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/j.2048-7940.2002.tb02020.x","volume":"27","author":"Sharts-Hopko","year":"2002","unstructured":"Sharts-Hopko NC, Sullivan MP (2002) Beliefs, perceptions, and practices related to osteoporosis risk reduction among women with multiple sclerosis. Rehabil Nurs 27:232\u2013236","journal-title":"Rehabil Nurs"},{"key":"1783_CR103","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.14.4.338","volume":"14","author":"Shatin","year":"1964","unstructured":"Shatin R (1964) Multiple sclerosis and geography. New interpretation of epidemiological observations. Neurology 14:338\u2013344","journal-title":"Neurology"},{"key":"1783_CR104","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1600-0404.1977.tb01459.x","volume":"56","author":"Shukla","year":"1977","unstructured":"Shukla VK, Jensen GE, Clausen J (1977) Erythrocyte glutathione perioxidase deficiency in multiple sclerosis. Acta Neurol Scand 56:542\u2013550","journal-title":"Acta Neurol Scand"},{"key":"1783_CR105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/07315724.2002.10719248","volume":"21","author":"Simopoulos","year":"2002","unstructured":"Simopoulos AP (2002) Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495\u2013505","journal-title":"J Am Coll Nutr"},{"key":"1783_CR106","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp.27.2.174","volume":"27","author":"Simpson","year":"1964","unstructured":"Simpson CA (1964) Vitamin B12 Levels in the serum and cerebrospinal fluid in multiple sclerosis. J Neurol Neurosurg Psychiatry 27:174\u2013177","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR107","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3181\/00379727-75-18319","volume":"75","author":"Simson","year":"1950","unstructured":"Simson G, Herfort A, Krim M et al. (1950) Effects of vitamin B12 in multiple sclerosis. Proc Soc Exp Biol Med 75:721","journal-title":"Proc Soc Exp Biol Med"},{"key":"1783_CR108","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/S0003-9993(03)00466-0","volume":"84","author":"Slawta","year":"2003","unstructured":"Slawta JN, Wilcox AR, McCubbin JA et al. (2003) Health behaviors, body composition, and coronary heart disease risk in women with multiple sclerosis. Arch Phys Med Rehabil 84:1823\u20131830","journal-title":"Arch Phys Med Rehabil"},{"key":"1783_CR109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7224\/1537-2073-4.1.17","volume":"4","author":"Smelzer","year":"2000","unstructured":"Smelzer S, Zimmerman V, Capriotti T (2000) Osteoporosis risk factors and bone mineral densitiy in women with MS. Int J MS Care 4:17\u201329","journal-title":"Int J MS Care"},{"key":"1783_CR110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/ajcn\/50.1.136","volume":"50","author":"Smith","year":"1989","unstructured":"Smith DK, Feldman EB, Feldman DS (1989) Trace element status in multiple sclerosis. Am J Clin Nutr 50:136\u2013140","journal-title":"Am J Clin Nutr"},{"key":"1783_CR111","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1046\/j.1369-6513.2001.00111.x","volume":"4","author":"Somerset","year":"2001","unstructured":"Somerset M, Campbell R, Sharp DJ et al. (2001) What do people with MS want and expect from health-care services? Health Expect 4:29\u201337","journal-title":"Health Expect"},{"key":"1783_CR112","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000110705","volume":"1","author":"Spencely","year":"1982","unstructured":"Spencely M, Dick G (1982) Breast feeding and multiple sclerosis. Neuroepidemiology 1:216\u2013222","journal-title":"Neuroepidemiology"},{"key":"1783_CR113","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000441-195022040-00011","volume":"220","author":"Swank","year":"1950","unstructured":"Swank RL (1950) Multiple Sclerosis: a correlation of its incidence with dietary fat. Am J Med Sci 220:421\u2013430","journal-title":"Am J Med Sci"},{"key":"1783_CR114","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0002-8223(21)18155-6","volume":"36","author":"Swank","year":"1960","unstructured":"Swank RL (1960) Treatment of multiple sclerosis with a low-fat diet. J Am Diet Assoc 36:322\u2013325","journal-title":"J Am Diet Assoc"},{"key":"1783_CR115","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archneur.1970.00480290080009","volume":"23","author":"Swank","year":"1970","unstructured":"Swank RL (1970) Multiple sclerosis: twenty years on low fat diet. Arch Neurol 23:460\u2013474","journal-title":"Arch Neurol"},{"key":"1783_CR116","first-page":"468","volume":"131","author":"Swank","year":"1960","unstructured":"Swank RL, Bourdillon RB (1960) Multiple sclerosis: assessment of treatment with a modified low-fat diet. J Neurochem 131:468\u2013488","journal-title":"J Neurochem"},{"key":"1783_CR117","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0140-6736(90)91533-G","volume":"336","author":"Swank","year":"1990","unstructured":"Swank RL, Dugan BB (1990) Effect of low saturated fat diet in early and late cases of multiple sclerosis. Lancet 336:37\u201339","journal-title":"Lancet"},{"key":"1783_CR118","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1056\/NEJM195205082461901","volume":"246","author":"Swank","year":"1952","unstructured":"Swank RL, Lerstad O, Strom P et al. (1952) Multiple sclerosis in rural Norway; its geographic and occupational incidence in relation to nutrition. N Engl J Med 246:721\u2013728","journal-title":"N Engl J Med"},{"key":"1783_CR119","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-0404.1979.tb02980.x","volume":"60","author":"Szeinberg","year":"1979","unstructured":"Szeinberg A, Golan R, Ben Ezzer J et al. (1979) Decreased erythrocyte glutathione peroxidase activity in multiple sclerosis. Acta Neurol Scand 60:265\u2013271","journal-title":"Acta Neurol Scand"},{"key":"1783_CR120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0404.1981.tb00750.x","volume":"63","author":"Szeinberg","year":"1981","unstructured":"Szeinberg A, Golan R, Ben-Ezzer J et al. (1981) Glutathione peroxidase activity in various types of blood cells in multiple sclerosis. Acta Neurol Scand 63:67\u201375","journal-title":"Acta Neurol Scand"},{"key":"1783_CR121","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s004150050431","volume":"246","author":"Thomas","year":"1999","unstructured":"Thomas FJ, Wiles CM (1999) Dysphagia and nutritional status in multiple sclerosis. J Neurol 246:677\u2013682","journal-title":"J Neurol"},{"key":"1783_CR122","doi-asserted-by":"crossref","first-page":"4P","DOI":"10.1042\/bj1280004Pc","volume":"128","author":"Thompson","year":"1972","unstructured":"Thompson RH (1972) Fatty acid metabolism in multiple sclerosis. Biochem J 128:4P","journal-title":"Biochem J"},{"key":"1783_CR123","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/01376517-199906000-00004","volume":"31","author":"Timmerman","year":"1999","unstructured":"Timmerman GM, Stuifbergin AK (1999) Eating patterns in women with multiple sclerosis. J Neurosci Nurs 31:152\u2013158","journal-title":"J Neurosci Nurs"},{"key":"1783_CR124","first-page":"189","volume":"Neurol","author":"Tola","year":"1994","unstructured":"Tola MR, Granieri E, Malagu S et al. (1994) Dietary habits and multiple sclerosis. A retrospective study in Ferrara, Italy. Acta Neurol (Napoli) 16:189\u2013197","journal-title":"Acta"},{"key":"1783_CR125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/jnnp.39.8.767","volume":"39","author":"Tsang","year":"1976","unstructured":"Tsang WM, Belin J, Monro JA et al. (1976) Relationship between plasma and lymphocyte linoleate in multiple sclerosis. J Neurol Neurosurg Psychiatry 39:767\u2013771","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR126","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1055\/s-0028-1117441","volume":"76","author":"Uhlemann","year":"1951","unstructured":"Uhlemann HJ (1951) Erfahrungen bei der Behandlung der Multiplen Sklerose mit Evers-Di\u00e4t. Dtsch Med Wochenschr 76:1212\u20131214","journal-title":"Dtsch Med Wochenschr"},{"key":"1783_CR127","unstructured":"United States Department of Agriculture (2004) Nutrient data laboratory. National Nutrient Database for Standard Reference. http:\/\/www.nal.usda.gov\/fnic\/foodcomp\/Data\/SR16-1\/reports\/sr16-1pg.htm, accessed 03.05.2004"},{"key":"1783_CR128","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1097\/00007890-200005150-00032","volume":"69","author":"van","year":"2000","unstructured":"van Etten E, Branisteanu DD, Verstuyf A et al. (2000) Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. Transplantation 69:1932\u20131942","journal-title":"Transplantation"},{"key":"1783_CR129","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/ajcn\/69.5.842","volume":"69","author":"Vieth","year":"1999","unstructured":"Vieth R (1999) Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 69:842\u2013856","journal-title":"Am J Clin Nutr"},{"key":"1783_CR130","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1136\/jnnp.73.3.246","volume":"73","author":"Wade","year":"2002","unstructured":"Wade DT, Young CA, Chaudhuri KR et al. (2002) A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the \u201cCari Loder regime\u201d) in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 73:246\u2013249","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1783_CR131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1210\/jcem-67-2-373","volume":"67","author":"Webb","year":"1988","unstructured":"Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373\u2013378","journal-title":"J Clin Endocrinol Metab"},{"key":"1783_CR132","first-page":"A461","volume":"58","author":"Weinstock-Guttmann","year":"2002","unstructured":"Weinstock-Guttmann B, Baier M, LeeKwen P et al. (2002) A randomized study of low-fat diet with omega-3 fatty acid supplementation in patients with relapsing-remitting multiple sclerosis (RRMS). Neurology 58:A461-A462","journal-title":"Neurology"},{"key":"1783_CR133","first-page":"397","volume":"57","author":"Westlund","year":"1953","unstructured":"Westlund KB, Kurland LT (1953) Studies on multiple sclerosis in Winnipeg, Manitoba, and New Orleans, Lousiana. Am J Hyg 57:397\u2013407","journal-title":"Am J Hyg"},{"key":"1783_CR134","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-277x.2000.00221.x","volume":"13","author":"White","year":"2000","unstructured":"White R, Ashworth A (2000) How drug therapy can affect, threaten and compromise nutritional status. J Hum Nutr Diet 13:119\u2013129","journal-title":"J Hum Nutr Diet"},{"key":"1783_CR135","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0404.1976.tb04806.x","volume":"54","author":"Wikstrom","year":"1976","unstructured":"Wikstrom J, Westermarck T, Palo J (1976) Selenium, vitamin E and copper in multiple sclerosis. Acta Neurol Scand 54:287\u2013290","journal-title":"Acta Neurol Scand"},{"key":"1783_CR136","first-page":"321","volume":"42","author":"Williams","year":"1988","unstructured":"Williams CM, Lines CM, McKay EC (1988) Iron and zinc status in multiple sclerosis patients with pressure sores. Eur J Clin Nutr 42:321\u2013328","journal-title":"Eur J Clin Nutr"},{"key":"1783_CR137","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1055\/s-2007-996363","volume":"65","author":"Winterholler","year":"1997","unstructured":"Winterholler M, Erbguth F, Neund\u00f6rfer B (1997) Verwendung paramedizinischer Verfahren durch MS-Patienten\u2014Patientencharakterisierung und Anwendungsgewohnheiten. Fortschr Neurol Psychiatr 65:555\u2013561","journal-title":"Fortschr Neurol Psychiatr"},{"key":"1783_CR138","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00017285-199311000-00004","volume":"28","author":"Wozniak-Wowk","year":"1993","unstructured":"Wozniak-Wowk CS (1993) Nutrition intervention in the management of multiple sclerosis. Nutr Today 28:12\u201320","journal-title":"Nutr Today"},{"key":"1783_CR139","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0404.1983.tb04844.x","volume":"68","author":"Yoshida","year":"1983","unstructured":"Yoshida M, Takase S, Itahara K et al. (1983) Linoleate and fatty acid compositions in the serum lipids of Japanese patients with multiple sclerosis. Acta Neurol Scand 68:362\u2013364","journal-title":"Acta Neurol Scand"},{"key":"1783_CR140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1212\/WNL.57.1.75","volume":"57","author":"Zhang","year":"2001","unstructured":"Zhang SM, Hernan MA, Olek MJ et al. (2001) Intakes of carotenoids, vitamin C, and vitamin E and MS risk among two large cohorts of women. Neurology 57:75\u201380","journal-title":"Neurology"},{"key":"1783_CR141","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/aje\/152.11.1056","volume":"152","author":"Zhang","year":"2000","unstructured":"Zhang SM, Willett WC, Hernan MA et al. (2000) Dietary fat in relation to risk of multiple sclerosis among two large cohorts of women. Am J Epidemiol 152:1056\u20131064","journal-title":"Am J Epidemiol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00115-004-1783-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1783-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-004-1783-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T09:28:45Z","timestamp":1699349325000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00115-004-1783-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":141,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1007\/s00115-004-1783-7","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2]]}}}